Sanguine Biosciences Announces $10 Million Credit Financing from Catalio Capital Management to Fund Continued Growth
Capital infusion fast-tracks the development of apheresis-derived products critical to cell and gene therapy research and manufacturing.
Sep 26, 2023
Sanguine Biosciences Opens New Apheresis Donor Center in Los Angeles
Sanguine will collect concentrated white blood cell biospecimens through apheresis from participants in Sanguine’s Southern California Patient Community…
